Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Heart failure

Weekly contact with pharmacist improves medicine adherence in people with heart failure

Researchers discovered that additional pharmacy care improved patients’ quality of life after two years. 

Regular consultations with pharmacists lead to improved medicine adherence in people with chronic heart failure (HF), research results published in the European Journal of Heart Failure show (25 May 2019)[1].

The trial involved 237 people from Germany aged ≥60 years with chronic HF receiving diuretic treatment and whose condition had worsened or required hospitalisation in the prior 12 months.

Patients were randomly assigned to usual care or pharmacy care, which meant they received a medication review followed by regular dose dispensing and counselling every one to two weeks.

Over a period of 365 days, the pharmacy group filled prescriptions for 91.2% of days versus 85.5% for the usual care group. The intervention group were 2.9 times more likely to be classed as adherent (≥80% days covered) than the usual care group (86.0 vs 68.0%).

Overall, the researchers found that the pharmacy care intervention improved quality of life after two years, compared with usual care.

Previous research has shown that 30–50% of people with chronic HF are non-adherent to their medicine, which can lead to a resurgence of symptoms and impaired quality of life.

“Pharmacy care represents a valuable addition to the comprehensive care for HF patients,” the authors wrote, adding that effects of the intervention on morbidity and mortality needed to be assessed in a larger randomised trial.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2019.20206683

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.